Lynx Investment Advisory »

AstraZeneca shares owned by Lynx Investment Advisory

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Lynx Investment Advisory from 13F filings

Historical chart of Lynx Investment Advisory investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Lynx Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Lynx Investment Advisory

Quarter filed Position value Share count Share price at filing
2024-09-30 $217k 2.8k 77.91
2024-06-30 $209k 2.7k 77.99

More positions owned by Lynx Investment Advisory

Invesco S&p 500 Quality Etf Etf (SPHQ)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Apple Stock (AAPL)
Proshares S&p 500 Dividend Aristocrats Etf Etf (NOBL)
Dimensional International Core Equity Market Etf Etf (DFAI)
First Trust Dow Jones Global Select Dividend Index Fund Etf (FGD)
Ishares Intl Dividend Growth Etf Etf (IGRO)
Microsoft Corp Stock (MSFT)
Spdr Gold Shares Etf Etf (GLD)
Spdr Gold Minishares Trust Etf (GLDM)
Spdr Portfolio S&p 400 Mid Cap Etf Etf (SPMD)
Mastercard Incorporated Cl A Stock (MA)
Invesco S&p Global Water Index Etf Etf (CGW)
Amazon Stock (AMZN)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)

View all positions for Lynx Investment Advisory

Top funds holding AstraZeneca

T. Rowe Price Associates
PRIMECAP Management Company
Capital Research and Management Company - Division 3
Franklin Resources
Jennison Associates
Sanders Capital
Goldman Sachs Group
Morgan Stanley
Fisher Investments
Atlantic Trust
Bank of America Corporation
BlackRock
Capital World Investors
BlackRock
GQG Partners

View all funds holding AstraZeneca